Siga Technologies (SIGA) Long-Term Deferred Tax (2011 - 2025)
Siga Technologies (SIGA) posted Long-Term Deferred Tax of $4.4 million for Q4 2025, up 183.8% on a QoQ basis from $1.6 million in Q3 2025, and down 59.2% year-over-year from $10.9 million in Q4 2024.
Siga Technologies (SIGA) Long-Term Deferred Tax (2011 - 2025) Analysis & Trends
Siga Technologies' Long-Term Deferred Tax history runs 15 years deep, the most recent figure standing at $4.4 million for Q4 2025.
- Quarterly Long-Term Deferred Tax fell 59.2% year-over-year to $4.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (down 59.2% YoY) and the FY2025 annual result came in at $4.4 million, down 59.2% from the prior year.
- Long-Term Deferred Tax was $4.4 million for Q4 2025 at Siga Technologies, up from $1.6 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $12.1 million in Q3 2024 and bottomed at $1.6 million in Q3 2025.
- A 5-year average of $6.4 million and a median of $5.3 million in 2022 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax soared 158.0% — and 2025, when it slumped 87.11%.
- Siga Technologies' Long-Term Deferred Tax stood at $2.4 million in 2021, then surged by 158.0% to $6.3 million in 2022, then jumped by 76.76% to $11.0 million in 2023, then slipped by 1.75% to $10.9 million in 2024, then slumped by 59.2% to $4.4 million in 2025.
- Business Quant data shows SIGA's Long-Term Deferred Tax at $4.4 million in Q4 2025, $1.6 million in Q3 2025, and $4.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.43 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | 3.97 Mn |
| Mar 31, 2025 | 11.13 Mn |
| Dec 31, 2024 | 10.85 Mn |
| Sep 30, 2024 | 12.10 Mn |
| Jun 30, 2024 | 11.61 Mn |
| Mar 31, 2024 | 11.01 Mn |
| Dec 31, 2023 | 11.05 Mn |
| Sep 30, 2023 | 7.90 Mn |
| Jun 30, 2023 | 7.59 Mn |
| Mar 31, 2023 | 6.73 Mn |
| Dec 31, 2022 | 6.25 Mn |
| Sep 30, 2022 | 4.18 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 4.04 Mn |
| Dec 31, 2021 | 2.42 Mn |
| Sep 30, 2021 | 2.95 Mn |
| Jun 30, 2021 | 2.73 Mn |
| Mar 31, 2021 | 2.57 Mn |